Safety and Effectiveness of Apixaban Versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation Stratified by Renal Function: A Retrospective Cohort Study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and Effectiveness of Apixaban Versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation Stratified by Renal Function: A Retrospective Cohort Study
Authors
Keywords
-
Journal
American Journal of Cardiovascular Drugs
Volume 23, Issue 6, Pages 721-733
Publisher
Springer Science and Business Media LLC
Online
2023-10-17
DOI
10.1007/s40256-023-00611-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 10-Year Trends of Antithrombotic Therapy Status and Outcomes in Japanese Atrial Fibrillation Patients ― The Fushimi AF Registry ―
- (2022) Masaharu Akao et al. CIRCULATION JOURNAL
- JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
- (2022) Katsushige Ono et al. CIRCULATION JOURNAL
- Chronic kidney disease and atrial fibrillation: A dangerous combination
- (2022) Gurbey Ocak et al. PLoS One
- Effectiveness and Safety of Reduced and Standard Daily Doses of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: A Cohort Study Using National Database Representing the Japanese Population
- (2022) Kiyoshi Kubota et al. Clinical Epidemiology
- Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants
- (2022) Marco Trevisan et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Two-Week Burden of Arrhythmias across CKD Severity in a Large Community-Based Cohort: The ARIC Study
- (2021) Esther D. Kim et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC
- (2021) Gerhard Hindricks et al. EUROPEAN HEART JOURNAL
- Comparative Safety and Effectiveness of Apixaban vs. Warfarin in Oral Anticoagulant-Naïve Japanese Patients With Non-Valvular Atrial Fibrillation ― A Retrospective Chart Review Study ―
- (2021) Yukihiro Koretsune et al. CIRCULATION JOURNAL
- Chronic kidney disease and risk of atrial fibrillation and heart failure in general population‐based cohorts: the BiomarCaRE project
- (2021) Martin Rehm et al. ESC Heart Failure
- Apixaban vs. Warfarin in Atrial Fibrillation Patients With Chronic Kidney Disease
- (2021) Chung-Ming Fu et al. Frontiers in Cardiovascular Medicine
- Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge
- (2020) Giuseppe Lippi et al. International Journal of Stroke
- Relationship between the Renal Function and Adverse Clinical Events in Patients with Atrial Fibrillation: A Japanese Multicenter Registry Substudy
- (2020) Yasuhumi Yuzawa et al. Journal of Clinical Medicine
- Impact of creatinine clearance on clinical outcomes in elderly atrial fibrillation patients receiving apixaban: J-ELD AF Registry subanalysis
- (2020) Masaharu Akao et al. AMERICAN HEART JOURNAL
- Outcomes associated with apixaban vs warfarin in patients with renal dysfunction
- (2020) Claudia Hanni et al. Blood Advances
- Pathophysiology of Atrial Fibrillation and Chronic Kidney Disease
- (2020) Wern Yew Ding et al. CARDIOVASCULAR RESEARCH
- Comparative Effectiveness and Safety of Oral Anticoagulants Across Kidney Function in Patients With Atrial Fibrillation
- (2020) Xiaoxi Yao et al. Circulation-Cardiovascular Quality and Outcomes
- Efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and chronic kidney disease stage G4
- (2020) Heleniak Zbigniew et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Oral anticoagulation in patients with chronic kidney disease
- (2019) Konark Malhotra et al. NEUROLOGY
- Worsening renal function, adverse clinical events and major determinants for changes of renal function in patients with atrial fibrillation: a Japanese multicenter registry substudy
- (2019) Keiichiro Kuronuma et al. CURRENT MEDICAL RESEARCH AND OPINION
- Characterizing the Safety Profile of Apixaban Versus Warfarin in Moderate to Severe Chronic Kidney Disease at a Veterans Affairs Hospital
- (2019) Kyle Herndon et al. ANNALS OF PHARMACOTHERAPY
- Variability in Non–Vitamin K Antagonist Oral Anticoagulants Dose Adjustment in Atrial Fibrillation Patients With Renal Dysfunction: The Influence of Renal Function Estimation Formulae
- (2018) Jason G. Andrade et al. CANADIAN JOURNAL OF CARDIOLOGY
- Renal Dysfunction Affects Anticoagulation Control With Warfarin and Outcomes in Japanese Elderly Patients With Non-Valvular Atrial Fibrillation
- (2018) Hiroshi Inoue et al. CIRCULATION JOURNAL
- Incident Atrial Fibrillation and the Risk of Stroke in Adults with Chronic Kidney Disease
- (2018) Juan Jesus Carrero et al. Clinical Journal of the American Society of Nephrology
- Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation
- (2018) C. Becattini et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The Efficacy and Safety of Direct Oral Anticoagulants in Patients with Chronic Renal Insufficiency: A Review of the Literature
- (2018) Jacob Weber et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation
- (2017) Xiaoxi Yao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparison of the Safety and Effectiveness of Apixaban versus Warfarin in Patients with Severe Renal Impairment
- (2017) Brooke E. Stanton et al. PHARMACOTHERAPY
- Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time
- (2016) Ziad Hijazi et al. JAMA Cardiology
- Impact of renal function deterioration on adverse events during anticoagulation therapy using non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2015) Koji Miyamoto et al. HEART AND VESSELS
- Atrial fibrillation and incident end-stage renal disease: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study
- (2015) Wesley T. O'Neal et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now